首页> 外国专利> ARYL-AND HETEROARYLETHANOL-PYRIDYLALKYLAMINES, PROCESS FOR THE PREPARATION THEROF AND THE USE THERE OF AS PRODUCTION PROMOTERS IN LIVESTOCK AND AS AGENTS AGAINST OBESITY

ARYL-AND HETEROARYLETHANOL-PYRIDYLALKYLAMINES, PROCESS FOR THE PREPARATION THEROF AND THE USE THERE OF AS PRODUCTION PROMOTERS IN LIVESTOCK AND AS AGENTS AGAINST OBESITY

机译:芳基-和杂芳基-羟基-吡啶烷基烷基酰胺,合成制剂的生产过程以及在牲畜和肥胖中用作生产促进剂的过程

摘要

Novel aryl- and heteroarylethanolpyridylalkylamines of the formula I …IMAGE… in which… A stands for =CH- or =N-,… R0 stands for hydrogen or methyl,… R1 stands for hydrogen, hydroxyl, halogen, cyano, alkyl, haloalkyl, hydroxyalkyl, alkoxycarbonyl, aminocarbonyl, mono- and dialkylaminocarbonyl, alkoxy, haloalkoxy, haloalkylthio or NHSO2-alkyl,… R2 stands for hydrogen, hydroxyl, alkoxy or the radical -NR5R6,… R3 stands for the radicals given under R1,… R4 stands for hydrogen, C1-C10-alkyl which is optionally substituted by hydroxyl, halogen, alkoxy, acyloxy or the radical -NR7R8, and also for the radical COR9 or the radical -O-Z-R10,… Z stands for C1-C10-alkylene, -alkenylene or alkynylene,… R5 represents hydrogen or alkyl,… R6 represents hydrogen, alkyl, haloalkyl or acyl, where R5 and R6, together with the adjacent N atom, can form a saturated or unsaturated heterocyclic 4-, 5- or 6-membered ring,… R7 stands for hydrogen, optionally substituted alkyl or optionally substituted aryl,… R8 stands for the radicals indicated under R7,… R9 stands for hydroxyl, alkoxy or the radical -NR7R8,… R10 stands for hydroxyl, alkoxy, acyloxy, optionally substituted aryloxy or aralkyloxy,… where in the pyridyl ring of the formula I the substituent R4 and the alkylamino group are in the p-position to one another,… and their physiologically tolerable salts and, if A stands for nitrogen, their N-oxides. …??The present invention furthermore relates to processes for the preparation of the compounds, intermediates used in this process, and their use as performance promoters in animals and as anti-obesity agents.
机译:式I的新的芳基-和杂芳基乙醇吡啶基烷基胺... ...,其中... A代表= CH-或= N-,... R <0>代表氢或甲基,... R <1代表氢,羟基,卤素,氰基,烷基,卤代烷基,羟烷基,烷氧基羰基,氨基羰基,单和二烷基氨基羰基,烷氧基,卤代烷氧基,卤代烷硫基或NHSO 2-烷基,…R 2代表氢,羟基,烷氧基或-NR 5 R基团<6>,...,R 3代表R 1,...,R 4代表氢,C1-C10-烷基,其任选地被羟基,卤素,烷氧基,酰氧基或- NR 7 R 8,以及基团COR 9或基团-OZR 1 <0>,…Z代表C 1 -C 10亚烷基,亚链烯基或亚炔基,…R 5。代表氢或烷基,…R 6代表氢,烷基,卤代烷基或酰基,其中R 5和R 6与相邻的N原子一起可形成饱和或不饱和杂环4-,5-或- 6元环,…R 7代表氢,可选取代的烷基1或任选取代的芳基,... R 8代表R 7所示的基团,... R 9代表羟基,烷氧基或-NR 7 R 8,... R 1 <0>代表羟基,烷氧基,酰氧基,任选取代的芳氧基或芳烷氧基,…,其中在式I的吡啶基环中,取代基R 4和烷基氨基彼此位于对位,…及其生理上可接受的盐,如果A代表氮,则指其N-氧化物。本发明还涉及化合物的制备方法,该方法中使用的中间体,以及它们在动物中作为性能促进剂和作为抗肥胖剂的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号